Good news In case you have not heard Bristol Myers is filing in japan for first oral treatment for genotype one .
We are not in Japan but still good news as I think Gilead and Abbvie will push harder to release there products faster , big companies and money talks .
Also this is good I think because if it was only Gilead in this race , the price of the there treatment would be extremely expensive as Gilead are well known to be very expensive .
Abbvie , Bristol Myers and Gilead will price more fairly I believe now as there is huge market .
2014 should be a good year to many of us .
In the multibillion-dollar race to bring oral hepatitis C treatments to market, Bristol-Myers Squibb is leapfrogging Gilead Sciences and Johnson & Johnson by filing for approval for daclatasvir with Japan's Pharmaceutical and Medical Devices Agency.
The daclatasvir and asunaprevir combo therapy is the first all-oral treatment to be filed for approval, eliminating side-effect-riddled interferon and ribavirin. Bristol's strategic move to go for a Japan launch rather than battle Gilead's sofosbuvir and J&J's simeprevir in the United States is a dramatic shift for the industry and may mark a shift in global drug development toward Japan -- a country in the midst of redefining itself as R&D friendly.
I think you make a good point. If it wasn't for the profit motive the companies wouldn't be competing so ferociously. If price is fixed or socialized down investors will invest elsewhere other than drug companies that create new drugs. Capitalism and competition save lives.
Profit motive for these companies is huge we are lucky they have competition prices will much more competitive and fair which will mean easier access with insurance companies , pbs , developing countries and so forth , if it was a one horse race prices prices would be ridiculous especially with gilead .
My opinion is that Abbvie and Gilead will be filing for fda sooner than many expect as this year just as sofosbuvir was filed earlier than many predicted , there is to much money at stake and money is there only motive .
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.